USPTO serial 87943280
THE INTELLIGENT PLATFORM FOR LIFE SCIENCES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 16, 2020
- Examiner
- PERRY, KIMBERLY B
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with THE INTELLIGENT PLATFORM FOR LIFE SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jordan A LaVine
JORDAN A LAVINE FLASTER GREENBERG PC1835 MARKET STREET, SUITE 1050PHILADELPHIA, PA 19103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Platform as a service (PAAS) featuring computer software platforms for use with managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Cloud computing featuring software for use with managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Consulting services for others in the field of design, planning, and implementation project management of clinical trials and medical research; Providing a website featuring educational information in the field of clinical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of on-line non-downloadable cloud computing software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Software as a service (SAAS) services featuring software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 13, 2020 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 16, 2020 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| May 14, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 8, 2020 | EXPT | EXPARTE APPEAL TERMINATED | — |
| May 8, 2020 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| May 8, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 8, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 1, 2020 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Apr 30, 2020 | IUAA | USE AMENDMENT ACCEPTED | — |
| Apr 20, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 17, 2020 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Apr 17, 2020 | IUAF | USE AMENDMENT FILED | — |
| Apr 16, 2020 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Feb 19, 2020 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 19, 2020 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 19, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 19, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 19, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 12, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 14, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 6, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 25, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 4, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 26, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 26, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2018 | NWAP | NEW APPLICATION ENTERED | — |